NASDAQ: HTBX is set for a 7% increase on Thursday, following Wednesday's leap of the same scale.
Speculation that Heat Biologics may receive a government grant may continue fueling the rally.
Promising pre-clinical data in its coronavirus-vaccine candidate is keeping the stock bid.
The race to develop immunization for coronavirus vaccine is warming up – with Heat Biologics (NASDAQ: HTBX) gaining speed. The Morrisville, North Carolina based firm has yet to generate revenue – but it may receive support from Uncle Sam. The US government has been generously awarding funds to firms working on immunization to COVID-19 – including Kodak, a company that filed for Chapter 11.
daniberar
Posts
-
-
Funding is coming, The race to develop immunization for coronavirus vaccine is warming up – with Heat Biologics (NASDAQ: HTBX) gaining speed. The Morrisville, North Carolina based firm has yet to generate revenue – but it may receive support from Uncle Sam. The US government has been generously awarding funds to firms working on immunization to COVID-19 – including Kodak,
-
Shorts are gone, and tomorrow they will have to buy at a much bigger price
-
Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies
ACCESSWIREJuly 29, 2020, 1:30 PM
Confirms stimulation of human-HLA-restricted transgenic mouse T-cells against immunodominant epitopes of SARS-CoV-2 Spike proteinDURHAM, NC / ACCESSWIRE / July 29, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced successful pre-clinical testing of the Company's COVID-19 vaccine
-
While Heat is well behind the leaders in the race to develop a COVID-19 vaccine, these positive preclinical data could open the door for a lucrative collaboration with a big-name pharma or perhaps a sizable government grant. The U.S. federal government has been extremely generous in terms of funding when it comes to developmental-stage coronavirus vaccines in general.
-
Just read the new NEWS, in August this will be 7$ https://www.google.com.mt/amp/s/www.fool.com/amp/investing/2020/07/29/why-heat-biologics-stock-is-spiking-today.aspx
-
Told you, caboooom
-
Every one is buying can’t go down anymore, august is here, PR is coming, and this atomic bomb will explode
-
Explosion is coming
-
Specifically, Heat announced that its COVID-19 vaccine candidate exhibited compelling evidence of immunogenicity (the ability to provoke a body's immune response) in a preclinical (animal) study. Although the biotech's shares have cooled off a bit over the course of today's session, they are still up by a noteworthy 20% as of 10:56 a.m. EDT.
-
Seems like a good day with new news. https://www.google.com.mt/amp/s/seekingalpha.com/amp/news/3596617-heat-biologics-covidminus-19-vaccine-shows-encouraging-action-in-preclinical-study
HTBX
HTBX
HTBX
HTBX
GNUS
GNUS
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
HTBX
TRIB